Clinical trial
A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline…
NCT00143286 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143286 |
|---|---|
| Title | A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation |
| Official title | A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline ( CP-526,555) for the Maintenance of Smoking Cessation |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Smoking Cessation |
| Intervention type | Drug |
| Interventions | varenicline (CP-526, 555) |
| Enrollment | 2,000 |
| Start date | Apr 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Sep 2, 2005 |
| Last update posted | Jun 4, 2007 |
| Countries | Canada, Czechia, Denmark, Norway, Sweden, United Kingdom, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: